Manar Matar

684 total citations
35 papers, 392 citations indexed

About

Manar Matar is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Manar Matar has authored 35 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 20 papers in Genetics and 19 papers in Surgery. Recurrent topics in Manar Matar's work include Microscopic Colitis (20 papers), Inflammatory Bowel Disease (18 papers) and Eosinophilic Esophagitis (9 papers). Manar Matar is often cited by papers focused on Microscopic Colitis (20 papers), Inflammatory Bowel Disease (18 papers) and Eosinophilic Esophagitis (9 papers). Manar Matar collaborates with scholars based in Israel, United Kingdom and United States. Manar Matar's co-authors include Raanan Shamir, Amit Assa, Anat Guz‐Mark, Oren Ledder, Batia Weiss, Dan Turner, Firas Rinawi, Chani Topf‐Olivestone, Baruch Yerushalmi and Ron Shaoul and has published in prestigious journals such as Gastroenterology, Alimentary Pharmacology & Therapeutics and Archives of Disease in Childhood.

In The Last Decade

Manar Matar

30 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manar Matar Israel 9 281 216 106 105 58 35 392
Mirjam Bueno de Mesquita Italy 8 300 1.1× 232 1.1× 63 0.6× 184 1.8× 74 1.3× 11 439
Firas Rinawi Israel 15 502 1.8× 395 1.8× 143 1.3× 224 2.1× 102 1.8× 43 697
Natália Sousa Freitas Queiroz Brazil 12 143 0.5× 104 0.5× 52 0.5× 107 1.0× 78 1.3× 46 346
Jean‐Louis Giniès France 7 229 0.8× 269 1.2× 83 0.8× 164 1.6× 239 4.1× 9 477
Anna Fábián Hungary 12 154 0.5× 117 0.5× 67 0.6× 165 1.6× 66 1.1× 63 440
David Ong Singapore 11 117 0.4× 100 0.5× 68 0.6× 123 1.2× 39 0.7× 18 360
Grzegorz Oracz Poland 14 188 0.7× 129 0.6× 171 1.6× 377 3.6× 81 1.4× 57 651
Anne Breton France 8 139 0.5× 79 0.4× 61 0.6× 130 1.2× 73 1.3× 19 326
Sheila Viola France 8 399 1.4× 391 1.8× 108 1.0× 273 2.6× 265 4.6× 10 665
Marianne Kajbæk Vester-Andersen Denmark 15 407 1.4× 358 1.7× 47 0.4× 193 1.8× 28 0.5× 19 533

Countries citing papers authored by Manar Matar

Since Specialization
Citations

This map shows the geographic impact of Manar Matar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manar Matar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manar Matar more than expected).

Fields of papers citing papers by Manar Matar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manar Matar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manar Matar. The network helps show where Manar Matar may publish in the future.

Co-authorship network of co-authors of Manar Matar

This figure shows the co-authorship network connecting the top 25 collaborators of Manar Matar. A scholar is included among the top collaborators of Manar Matar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manar Matar. Manar Matar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matar, Manar, Raffi Lev‐Tzion, Oren Ledder, et al.. (2025). A switch to infliximab may be more effective than ustekinumab following adalimumab pharmacodynamic failure in paediatric patients with Crohn’s disease. Digestive and Liver Disease. 57(9). 1787–1793.
2.
Guz‐Mark, Anat, Noam Zevit, Orith Waisbourd‐Zinman, et al.. (2025). Long‐term laboratory follow‐up is essential in pediatric patients with celiac. Journal of Pediatric Gastroenterology and Nutrition. 80(5). 816–823.
3.
Matar, Manar, Yael Weintraub, Dror S. Shouval, et al.. (2025). Tumor necrosis factor α inhibitor-induced alopecia in pediatric patients: a cohort of 20 patients and review of the literature. Archives of Dermatological Research. 317(1). 799–799. 1 indexed citations
4.
Stein, Ronen, Dan Turner, Séamus Hussey, et al.. (2025). Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab: Results From the VedoKids Prospective Multicentre Study. Alimentary Pharmacology & Therapeutics. 61(6). 1000–1010. 1 indexed citations
5.
Schvimer, Michael, Jeffrey D. Goldsmith, Manar Matar, et al.. (2024). Clinical characteristics and outcomes of pediatric patients with autoimmune gastritis. Journal of Pediatric Gastroenterology and Nutrition. 79(3). 501–509. 2 indexed citations
6.
Tal, Noa, Tsachi Tsadok Perets, Manar Matar, et al.. (2024). Different infliximab induction dosing regimens do not affect remission rates up to 1 year in children with Crohn's disease. Journal of Pediatric Gastroenterology and Nutrition. 79(3). 564–572. 1 indexed citations
7.
Guz‐Mark, Anat, Noam Zevit, Orith Waisbourd‐Zinman, et al.. (2024). A significant increase in anthropometric indices during long-term follow-up of pediatric patients with celiac disease, with no endocrine disorders. European Journal of Pediatrics. 183(5). 2173–2182. 1 indexed citations
8.
Catassi, Giulia, Giulia D’Arcangelo, Lorenzo Norsa, et al.. (2023). Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN. Inflammatory Bowel Diseases. 30(10). 1662–1669. 7 indexed citations
9.
Dreznik, Yael, Inbal Samuk, Dror S. Shouval, et al.. (2023). Recurrence rates following ileo-colic resection in pediatric patients with Crohn’s disease. Pediatric Surgery International. 39(1). 83–83. 4 indexed citations
10.
Atia, Ohad, Diane R. Mould, Ronen Stein, et al.. (2022). Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study. ˜The œLancet. Gastroenterology & hepatology. 8(1). 31–42. 32 indexed citations
11.
Matar, Manar, et al.. (2022). Pediatric inflammatory bowel disease: Fecal calprotectin response to Anti-tumor necrosis factor alpha. Pediatric Research. 93(1). 131–136.
12.
Matar, Manar, et al.. (2021). Pediatric inflammatory bowel disease and the effect of COVID-19 pandemic on treatment adherence and patients’ behavior. Pediatric Research. 90(3). 637–641. 24 indexed citations
13.
Thomas, Abin, et al.. (2021). Liraglutide effects on glycemic control and weight in patients with type 2 diabetes Mellitus: A real-world, observational study and brief narrative review. Diabetes Research and Clinical Practice. 177. 108871–108871. 11 indexed citations
14.
Guz‐Mark, Anat, Noam Zevit, Luba Marderfeld, et al.. (2020). Two decades of pediatric celiac disease in a tertiary referral center: What has changed?. Digestive and Liver Disease. 52(4). 457–461. 14 indexed citations
15.
Assa, Amit, Manar Matar, Dan Turner, et al.. (2019). Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn’s Disease Compared With Reactive Monitoring. Gastroenterology. 157(4). 985–996.e2. 175 indexed citations
16.
Silbermintz, Ari, et al.. (2019). Endoscopic Findings in Children with Isolated Lower Gastrointestinal Bleeding. Clinical Endoscopy. 52(3). 258–261. 10 indexed citations
17.
Matar, Manar, et al.. (2019). Therapeutic Drug Monitoring Increases Drug Retention of Anti–Tumor Necrosis Factor Alpha Agents in Pediatric Patients With Crohn’s Disease. Inflammatory Bowel Diseases. 26(8). 1276–1282. 5 indexed citations
18.
Matar, Manar, Firas Rinawi, Raanan Shamir, & Amit Assa. (2017). Hypergammaglobulinemia is a marker of extraintestinal manifestations in pediatric inflammatory bowel disease. The Turkish Journal of Gastroenterology. 28(2). 131–134. 5 indexed citations
19.
Morgenstern, Sara, Gabriel Chodick, Manar Matar, et al.. (2017). Oesophageal eosinophilia in children with coeliac disease. Archives of Disease in Childhood. 102(9). 825–829. 10 indexed citations
20.
Watemberg, Nathan, et al.. (2013). The Influence of Excessive Chewing Gum Use on Headache Frequency and Severity Among Adolescents. Pediatric Neurology. 50(1). 69–72. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026